MENU
RSLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ReShape Lifesciences (RSLS) Ownership - Who owns ReShape Lifesciences?

Profile

Industry
Medical Specialties
Address
1001 Calle Amanecer
Phone
+1 949 429-6680
Employees
40
Web
https://www.reshapelifesciences.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
4.33M
P/E Ratio
N/A
Total Cash
1.45M
Projected Growth
N/A
Total Debt
285K
Revenue
9.81M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.06
Total Debt/Equity
N/A
Revenue/Share
4.40 USD as % of share price

Fundamentals

RSLS
Capitalization
4.33M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.45M
Total Cash/Share
0.06
Total Debt
285K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.40%
Revenue
9.81M
ROE
N/A
Book Value
3.08M
P/B Ratio
1.26
Cash Flow
N/A
Earnings
-38.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
1.66
Current Revenue Per Employee
53875.00
Dividends Per Share - Security
N/A
EBITDA
-36.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.77
Revenue To Assets
-144.19
Shares Held By Institutions
118K
Shares Outstanding - Current
23.5M
Total Liabilities
4.74M
Total Volume MTD
N/A
Value
1
Gain YTD
-64.302
View a ticker or compare two or three
RSLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical devices for the treatment of obesity

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1001 Calle Amanecer
Phone
+1 949 429-6680
Employees
40
Web
https://www.reshapelifesciences.com